CIBC Bancorp USA’s ResMed RMD Stock Holding History

CIBC Bancorp USA’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Buy	77,039 +26,440	+52%	+$5.48M	0.02%	475
2026 Q1	$11.4M	Buy	+50,599	New	+$12.6M	0.02%	472
2025 Q3	$5.53M	Buy	+20,207	New	+$5.52M	0.03%	384

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CIBC Bancorp USA's RMD Position: Q2 2026 in Review

CIBC Bancorp USA increased its ResMed (RMD) stake by 52% in Q2 2026, buying an estimated $5.48M and bringing the position to 77,039 shares worth $15M. The position accounts for 0.02% of the portfolio, ranked #475.

CIBC Bancorp USA first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

CIBC Bancorp USA held 77,039 shares of ResMed worth $15M as of Q2 2026.
CIBC Bancorp USA bought 26,440 ResMed shares in Q2 2026, an estimated $5.48M.
ResMed made up 0.02% of CIBC Bancorp USA's portfolio in Q2 2026, its #475 holding.
CIBC Bancorp USA first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.